News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,431 Results
Type
Article (7351)
Company Profile (41)
Press Release (258035)
Multimedia
Podcasts (16)
Webinars (5)
Section
Business (103703)
Career Advice (534)
Deals (16372)
Drug Delivery (18)
Drug Development (22550)
Employer Resources (39)
FDA (4145)
Job Trends (4778)
News (133681)
Policy (8463)
Tag
2027 BioCapital Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (437)
Accelerated approval (13)
ADA (15)
Adcomms (4)
Allergies (33)
Alliances (17398)
ALS (58)
Alzheimer's disease (397)
Antibody-drug conjugate (ADC) (137)
Approvals (4336)
Artificial intelligence (188)
ASCO (64)
Autoimmune disease (96)
Automation (18)
Bankruptcy (103)
Best Places to Work (3509)
BIO (28)
BIOSECURE Act (2)
Biosimilars (57)
Biotechnology (35)
Bladder cancer (51)
Brain cancer (24)
Breast cancer (186)
Cancer (1606)
Cardiovascular disease (102)
Career advice (456)
Career pathing (6)
CAR-T (123)
CDC (6)
Celiac Disease (1)
Cell therapy (312)
Cervical cancer (18)
Clinical research (20202)
Collaboration (734)
Commercialization (1)
Company closure (3)
Compensation (588)
Complete response letters (15)
COVID-19 (490)
CRISPR (30)
C-suite (644)
Cystic fibrosis (36)
Data (2483)
Denatured (8)
Depression (38)
Dermatology (30)
Diabetes (138)
Diagnostics (2584)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (13)
Drug discovery (105)
Drug pricing (24)
Drug shortages (2)
Duchenne muscular dystrophy (103)
Earnings (46276)
Editorial (10)
Employer branding (7)
Employer resources (40)
Events (45127)
Executive appointments (598)
FDA (5246)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (8)
Frontotemporal dementia (14)
Funding (625)
Gene editing (71)
Generative AI (10)
Gene therapy (187)
GLP-1 (228)
Government (611)
Guidances (220)
Healthcare (5669)
Hematology (58)
HIV (16)
Huntington's disease (16)
IgA nephropathy (45)
Immunology and inflammation (89)
Immuno-oncology (38)
Indications (54)
Infectious disease (554)
Inflammatory bowel disease (52)
Inflation Reduction Act (7)
Influenza (19)
Intellectual property (78)
Interviews (61)
IPO (8430)
IRA (8)
Job creations (1337)
Job search strategy (414)
JPM (8)
Kidney cancer (20)
Labor market (25)
Layoffs (154)
Leadership (10)
Legal (2516)
Liver cancer (28)
Longevity (10)
Lung cancer (172)
Lymphoma (112)
Machine learning (14)
Management (14)
Manufacturing (296)
Marketing (2)
MASH (81)
Medical device (4208)
Medtech (4257)
Mergers & acquisitions (8543)
Metabolic disorders (399)
mRNA (28)
Multiple sclerosis (50)
NASH (6)
Neurodegenerative disease (122)
Neuropsychiatric disorders (25)
Neuroscience (869)
NextGen: Class of 2026 (1940)
Non-profit (877)
Now hiring (23)
Obesity (164)
Opinion (56)
Ovarian cancer (74)
Pain (65)
Pancreatic cancer (94)
Parkinson's disease (89)
Partnered (9)
Patents (135)
Patient recruitment (207)
Peanut (7)
People (29013)
Pharmaceutical (8)
Pharmacy benefit managers (2)
Phase 1 (6401)
Phase 2 (8874)
Phase 3 (6859)
Pipeline (4004)
Policy (40)
Postmarket research (653)
Preclinical (2511)
Press Release (66)
Prostate cancer (83)
Psychedelics (8)
Radiopharmaceuticals (152)
Rare diseases (323)
Real estate (2201)
Recruiting (14)
Regulatory (6689)
Reports (21)
Research institute (447)
Resumes & cover letters (78)
Rett syndrome (33)
RNA editing (7)
RSV (5)
Schizophrenia (87)
Series A (124)
Series B (92)
Sickle cell disease (22)
Special edition (4)
Spinal muscular atrophy (39)
Sponsored (6)
Startups (1399)
Stomach cancer (4)
Supply chain (28)
Tariffs (9)
The Weekly (8)
Vaccines (200)
Venture capital (37)
Weight loss (72)
Women's health (32)
Worklife (2)
Date
Today (38)
Last 7 days (150)
Last 30 days (629)
Last 365 days (10845)
2026 (6218)
2025 (10867)
2024 (12910)
2023 (15378)
2022 (21150)
2021 (22383)
2020 (20349)
2019 (14693)
2018 (11301)
2017 (11337)
2016 (10360)
2015 (13393)
2014 (10605)
2013 (8638)
2012 (9469)
2011 (9783)
2010 (9482)
Location
Africa (222)
Alabama (24)
Alaska (2)
Arizona (101)
Arkansas (2)
Asia (13482)
Australia (1954)
California (5911)
Canada (1568)
China (333)
Colorado (226)
Connecticut (243)
Delaware (101)
Europe (29402)
Florida (743)
Georgia (109)
Hawaii (3)
Idaho (27)
Illinois (247)
India (31)
Indiana (200)
Iowa (9)
Japan (259)
Kansas (55)
Kentucky (20)
Louisiana (13)
Maine (58)
Maryland (480)
Massachusetts (4103)
Michigan (119)
Minnesota (257)
Mississippi (2)
Missouri (48)
Montana (18)
Nebraska (13)
Nevada (58)
New Hampshire (20)
New Jersey (1496)
New Mexico (5)
New York (1138)
North Carolina (730)
North Dakota (6)
Northern California (3080)
Ohio (191)
Oklahoma (7)
Oregon (10)
Pennsylvania (868)
Puerto Rico (4)
Rhode Island (23)
South America (313)
South Carolina (21)
Southern California (2324)
Tennessee (81)
Texas (819)
United States (18688)
Utah (155)
Vermont (1)
Virginia (122)
Washington D.C. (20)
Washington State (476)
West Virginia (3)
Wisconsin (85)
Wyoming (1)
265,431 Results for "valent biosciences corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genflow Biosciences PLC Announces Mid-Year Operational and Corporate Summary
July 13, 2026
·
9 min read
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
The star of the takeover is Forte Biosciences’ investigational antibody therapy, FB102, which has shown early potential in vitiligo and celiac disease.
July 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
U.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Disease
June 18, 2026
·
11 min read
Press Releases
Sagimet Biosciences Provides Strategic and Corporate Updates
April 27, 2026
·
7 min read
Press Releases
MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights
May 7, 2026
·
11 min read
BioMidwest
Valent BioSciences Opens New State-of-the-Art Addition at Melnik and Shafer Biorational Research Center
Valent BioSciences celebrated the grand opening of the new Venburg Wing at the company’s Melnik and Shafer Biorational Research Center in Libertyville, Illinois, during a special ceremony.
May 29, 2024
·
3 min read
Press Releases
Sagimet Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 12, 2026
·
8 min read
Press Releases
Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 14, 2026
·
11 min read
Press Releases
Enveric Biosciences Reports Financial Results and Provides Corporate Update for First Quarter 2026
May 17, 2026
·
8 min read
Press Releases
Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 8, 2026
·
10 min read
1 of 26,544
Next
